- Report
- April 2025
- 168 Pages
Global
From €5225EUR$5,450USD£4,366GBP
- Report
- March 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- February 2024
- 182 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Book
- April 2020
- 624 Pages
- Book
- October 2024
North America
- Book
- August 2024
North America
- Book
- March 2023
North America
- Book
- October 2021
North America
- Book
- July 2021
North America
- Book
- May 2019
North America
- Book
- August 2018
North America

Osteoporosis is a condition that affects the bones, making them weak and brittle. It is a common disorder in the field of endocrinology, and is most often seen in post-menopausal women. Osteoporosis is caused by a decrease in bone density, which can lead to an increased risk of fractures. Treatment for osteoporosis typically involves medications that help to increase bone density, as well as lifestyle changes such as increased physical activity and a balanced diet.
The osteoporosis market is a growing field, with a variety of treatments and products available. These include medications such as bisphosphonates, hormone replacement therapy, and selective estrogen receptor modulators. Additionally, there are a number of supplements and devices available to help improve bone health.
Some companies in the osteoporosis market include Amgen, Eli Lilly, Merck, Novartis, and Pfizer. Show Less Read more